What will Marc Beer bring to LumeNXT?

After being appointed as the board chairman of the Boston Based biotechnology firm LumeNXT, Marc Beer seems ready to help the company accomplish its goals. He is one of the most experienced professionals in this niche and so, the company could not have settled for anyone better. Recently, the company has been involved in the development of proprietary surgical illumination products. They are hoping to provide the perfect solution to modern challenges facing surgeons when they are carrying out surgeries that are minimally invasive. Following the new appointment, it is important to look at the value that he is likely to bring on board.

 

The company can leverage his experience

 

The position of a chairman to the board of any big company requires someone with a lot of experience. This is not the kind of position that you can just give to anyone because it requires exemplary leadership skills. In addition to that, it should be entrusted to someone who has been working in similar positions. Looking at Marc Beer, it is clear that he fits this description. He has been working in similar positions for more than 25 years and so, there is no doubt that he understands what the position entails. The company can leverage his experience to get fresh ideas that will help them to move forward.

 

He could replicate his previous success

 

Marc Beer comes to the company with a success record that many professionals at his level can only dream of. In the many positrons that he has held at various companies, he has helped to grow the organizations in many ways. It is because he combines his skills with talent to come up with unique ideas. The kinds of strategies that he uses are likely to change the fortunes of any company that he joins and so, LumeNXT hope that he will replicate his success. If only he can have the same effect as the one that he had in other places, the company will be better than he found it.

 

He is passionate about the new position

 

Another reason why LumeNXT should be happy with the appointment of Marc Beer is the fact that he is excited about joining the company. Immediately after being appointed, he said that he was product to be joining one of the best companies in the pharmaceuticals and biotechnology industry. He went further to say that he cannot wait to work with the team of engineers and surgeons. If he forms a good working relationship with this team, things will be rosy at the company.

 

Prior to his appointment as the chairman of the board of LumeNXT, Marc Beer had been working on many other companies for more than two decades. His contribution to the development of solutions in the medical industry is priceless. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing

 

Renovia and Marc Beer Raise Millions For Women’s Health Issues

Marc Beer has been the CEO and Chairman of Renovia since 2016 and in this time he has focused his efforts on addressing pelvic floor disorder, a condition that affects 250 million women in the world. For many years, the life-altering disorder did not have that many treatment options available. Even to this day, options are still rather limited which is something that Marc Beer and Renovia hope to be able to remedy so these women can live with less severe symptoms.

 

Renovia’s first product was approved by the Food and Drug Administration in the United States in April of 2018. The Leva device was funded through Marc Beer’s first round of capital raising for the company. With the second round of funding that was just recently completed in 2018, Marc Beer is expecting more products to reach the approval phase. The Series B round raised around $42 million for the company that has a strong focus on women’s health issues. There were investors from the first round who were impressed by the progress Renovia was able to make already and decided to put more of their capital into current and future products with the last round.

 

The device that was approved earlier in 2018 was designed to help train the muscles of the pelvic floor in order to strengthen them and give patients more control over their disorder. The device uses an interactive system that connects via Bluetooth with an app. Through the use of training, the product by Marc Beer’s Renovia was designed to improve the urinary incontinence issues that are very common among people with pelvic floor disorders. Marc Beer plans to release a new version of the state of the art device using some of the recently raised funding.

 

Aside from the new Leva device, there are 3 other products that Marc Beer’s company is currently working on that will be progressed using the most recent funding. These devices are being designed for not only therapeutic purposes like the Leva but also for diagnostic purposes as well. The company is happy with the amount of support that it has received through funding and belief in the vision that Marc Beer has for the company. Learn more: https://www.cnbc.com/video/2013/01/23/aegerion-ceo-on-promise-of-biopharma.html

 

Marc Beer has been an entrepreneur in different sectors of healthcare for more than 2 decades and has built quite a reputation over the years. Because of his leadership, his companies have been able to get many of their products approved by the FDA. The CEO and Chairman of Renovia also serves in the position of Chairman for Minerva Neuroscience as of 2013 and Good Start Genetics as of 2010.